Expression of p53, Ki-67 and c-erb B2 in growth hormone- and/or prolactin-secreting pituitary adenomas

被引:30
作者
Botelho, CHA
de Magalhaes, AVD
de Mello, PA
Schmitt, FC
Casulari, LA
机构
[1] Univ Brasilia, Dept Surg Pathol, Brasilia, DF, Brazil
[2] Univ Porto, Fac Med, Porto, Portugal
[3] Secretaria Estado Saude Distrito Fed, Brasilia, DF, Brazil
[4] Hosp Univ Brasilia, Brasilia, DF, Brazil
[5] Univ Porto, Fac Med, P-4100 Porto, Portugal
[6] IPATIMUP, Porto, Portugal
关键词
pituitary adenomas; growth hormone; prolactin; p53; Ki-67; c-erb B2; immunohistochemistry;
D O I
10.1590/S0004-282X2006000100013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The subcellular events implicated on the formation and behavior of pituitary adenomas are not fully understood. In this study we investigated the presence of p53, Ki-67 and c-erb B2 in 38 pituitary adenomas with immunohistochemical positivity for GH and prolactin (n=26; 68.4%), for prolactin (n=9; 23.7%) and for GH (n=3. 7.8%). The analyses revealed the following results: 24 (63.2%) tumors expressed variable positivity for c-erb B2, 11 (28.9%) expressed p53 positivity and 11 (28.9%) tumors were variably positive for Ki-67. Our results demonstrated a high percentage of GH/prolactin-, prolactin- and GH-secreting tumors with immunohistochemical positivity for c-erb B2. Once this membrane receptor is related to growth factors EGF and TGF alpha and both have a definite effect on tumor growth, our data suggest a possible role for c-erb B2 on the evolution of these tumors.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 28 条
[21]   Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas [J].
Onguru, O ;
Scheithauer, BW ;
Kovacs, K ;
Vidal, S ;
Jin, L ;
Zhang, SY ;
Ruebel, KH ;
Lloyd, RV .
MODERN PATHOLOGY, 2004, 17 (07) :772-780
[22]   Pituitary tumor diagnosis and treatment. [J].
Penar P.L. ;
Nathan D.J. ;
Nathan M.H. ;
Salsali A. .
Current Neurology and Neuroscience Reports, 2002, 2 (3) :236-245
[23]   Proliferation Markers in Different Types of Clinically Non-Secreting Pituitary Adenomas [J].
Silke Schreiber ;
Wolfgang Saeger ;
Dieter K. Lüdecke .
Pituitary, 1999, 1 (3-4) :213-220
[24]   Genetic basis of endocrine disease - Pituitary tumor pathogenesis [J].
Shimon, I ;
Melmed, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1675-1681
[25]   Genetic basis of pituitary adenoma invasiveness: A review [J].
Suhardja, A ;
Kovacs, K ;
Rutka, J .
JOURNAL OF NEURO-ONCOLOGY, 2001, 52 (03) :195-204
[26]   Mdm2 and the p53 pathway in human pituitary adenomas [J].
Suliman, M ;
Royds, J ;
Cullen, D ;
Timperley, W ;
Powell, T ;
Battersby, R ;
Jones, TH .
CLINICAL ENDOCRINOLOGY, 2001, 54 (03) :317-325
[27]   Bromocriptine induced apoptosis in pituitary adenoma cells: relationship to p53 and bcl-2 expression [J].
Yin, DL ;
Tamaki, N ;
Kokunai, T ;
Yasuo, K ;
Yonezawa, K .
JOURNAL OF CLINICAL NEUROSCIENCE, 1999, 6 (04) :326-331
[28]   DISTRIBUTION OF GROWTH-HORMONE AND PROLACTIN IN SECRETORY GRANULES OF THE NORMAL AND NEOPLASTIC HUMAN ADENOHYPOPHYSIS [J].
ZURSCHMIEDE, C ;
LANDOLT, AM .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1987, 53 (05) :308-315